Aclaris Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2017 | 28.3% | -3,230.0% | -4,071.5% |
| FY2018 | 52.7% | -1,378.3% | -2,158.0% |
| FY2019 | 4.1% | -2,627.3% | -3,817.2% |
| FY2020 | 20.8% | -785.4% | -787.0% |
| FY2021 | 30.3% | -1,327.1% | -1,344.0% |
| FY2022 | 86.5% | -302.0% | -292.1% |
| FY2023 | 89.0% | -311.6% | -283.1% |
| FY2024 | 85.1% | -758.2% | -705.5% |
| FY2025 | 73.3% | -975.9% | -829.6% |